Try our Advanced Search for more refined results
April 26, 2012
WARNER CHILCOTT COMPANY, LLC et al v. RANBAXY, INC. et al
Case Number:
2:12-cv-02474
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 27, 2012
Warner Chilcott Targets Ranbaxy's Osteoporosis Generic
Warner Chilcott Co. LLC on Thursday redoubled its efforts to protect its osteoporosis drug Atelvia, launching a new infringement suit accusing Ranbaxy Laboratories Ltd. of violating its patents by developing a generic version of the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login